Evergreen Capital Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,163	Closed	-$292K	–	961
2024 Q1	$292K	Buy	4,163 +758	+22%	+$53.1K	0.01%	641
2023 Q4	$284K	Buy	+3,405	New	+$284K	0.01%	614
2022 Q4	–	Sell	-4,217	Closed	-$204K	–	683
2022 Q3	$204K	Buy	+4,217	New	+$204K	0.01%	555